Bml Capital Management, Llc Portfolio Stock Holdings

According to the SEC 13F filed on August 7, 2026, Bml Capital Management, Llc disclosed 14 stock positions valued at approximately $175.10M as of quarter-end June 30, 2026. The largest holdings include ACLARIS THERAPEUTICS INC, ATEA PHARMACEUTICALS INC, and KRAFT HEINZ CO.

Report Period
June 30, 2026
No. of Stocks
14
Portfolio Value
$175.10M
Holdings by Sector
Bml Capital Management, Llc Portfolio Holdings in Q2 2026
CompanySymbolSectorPortfolio %SharesChange (Shares)Change %Value
ACLARIS THERAPEUTICS INCACRSHealthcare36.18%11,975,000-2,275,000-15.96%$63,347,750
ATEA PHARMACEUTICALS INCAVIRHealthcare18.46%6,952,330-106,327-1.51%$32,328,335
KRAFT HEINZ COKHCConsumer Defensive6.27%465,000+340,000+272.00%$10,983,300
OUTSET MED INCOMHealthcare6.22%2,519,701+617,500+32.46%$10,885,108
CARMAX INCKMXConsumer Cyclical5.21%172,500+17,500+11.29%$9,123,525
TILLYS INCTLYSConsumer Cyclical5.16%2,150,000--$9,030,000
PMV PHARMACEUTICALS INCPMVPHealthcare4.08%5,330,000+10,000+0.19%$7,142,200
INSTIL BIO INCTILHealthcare2.84%645,600--$4,964,664
TARGET CORPTGTConsumer Defensive2.80%37,500--$4,897,875
ORAMED PHARMACEUTICALS INCORMPHealthcare2.38%866,269-2,300,962-72.65%$4,166,754
JANUX THERAPEUTICS INCJANXHealthcare1.36%154,961--$2,380,201
PLIANT THERAPEUTICS INCPLRXHealthcare1.01%1,546,137--$1,762,596
CONNECT BIOPHARMA HLDGS LTDCNTBOther0.78%573,287+164,400+40.21%$1,364,423
IMAGENEBIO INCIMAOther0.68%200,730--$1,184,307
Showing 14 of 14 holdings in the latest reporting period.
Bml Capital Management, Llc Options Holdings in Q2 2026
QuarterSymbolCompanyOptionContractsNotional Value
Q2 2026WMTWalmart Inc.PUT335$386,088
Q2 2026CORZCore Scientific, Inc.PUT800$298,000
Q2 2026TSLATesla, Inc.PUT375$270,000
Showing 3 of 3 options positions in the latest reporting period.

Notional value represents the total exposure of the options position.